DV
Dividend Vision

ASND — Ascendis Pharma A/S

Ascendis Pharma A/S (ASND)

Total return is 1219.7% over the past 11.5 years, 850.1 points ahead of SPY at 369.6%. Its deepest 1-year drawdown was 17.6%.

ASND is a healthcare equity holding that tracks Ascendis Pharma A/S, a biopharmaceutical company. As an individual stock rather than a diversified fund, it does not provide dividend income—the company does not currently distribute earnings to shareholders. This holding appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical sector, rather than those focused on generating dividend yield.

ASND key facts

Asset type
Stock
Asset class
Equity
Inception date
01/28/2015
Distribution frequency
None
Last close
$248.50
Market cap
$16,299,819,008
Average volume
650400.0
Beta
0.485
Payout ratio
0.0
P/E ratio
19.2636
Forward P/E
15.4083
EPS
$12.90